You, B., Leary, A., Jamelot, M., Parent, P., Lebreton, C., Gladieff, L., Frenel, J., Provansal, M., Meurer, M., Rouge, T. D. L. M., D'hondt, V., Eberst, L., Vicier, C., Tomasini, P., Tosi, D., Calattini, S., Hajri, T., Schwiertz, V., Subtil, F., Bolze, P. (2025). IMMUNORARE
            <sup>5</sup>
            : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Gestational Trophoblastic Tumors Cohort.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps5636